RESEARCH TRIANGLE PARK, North Carolina, Feb. 18 /PRNewswire/ -- Marken announced today the appointment of Ms. Anastacia Kurianova as Technical Director, Marken Russia.
Ms. Kurianova will be responsible for the expansion of Marken's depot operations in Moscow and enhance the company's GDP compliance as the requirements for movement of drug product become more complex. She will also play a key role in refining the existing domestic network which underpins the Marken business.
Anastacia brings a decade of technical experience, having fulfilled significant roles in quality assurance at a pharmaceutical services company. She has also had extensive technical and leadership training which provides Marken with a unique combination of skills and talent. Gerit Offenhauser, Marken's Senior Vice President, Clinical Trials Distribution commented, "With her excellent experience in ISO 9001 requirements, GDP, GMP, Standard Operating Procedures, technical leadership, audit management, quality surveillance and risk mitigation, Anastascia is the ideal candidate as Marken establishes a stronger foothold in Russia. We look forward to her contributions and fulfilling our long term plan for growth in this region along with furthering our commitment to quality and service throughout Eastern Europe."
Marken, as the only Clinical Logistics Organization (CLO), has provided proven global logistics solutions to the pharma and life sciences industries for 35 years. Marken's services include cold chain packaging, active and passive, shipping qualification and validation, track and trace, and regulatory expertise. Their purpose-built GMP-compliant depots offer temperature controlled storage at all levels from 2-8 deg C, controlled room temperature and -20C, drug receipt, pick and pack, dispatch and drug return/destruction services. A fully trained and dedicated project management team supports each project.
Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. Marken integrates depot and logistics into solutions that extend the reach of clinical trials to even the most remote treatment-naive geographies.